In 1976, researchers identified low-molecular-weight heparins as shorter heparin-derived compounds with useful anticoagulant properties. These agents were later developed for more predictable dosing and convenient subcutaneous use. They became important for preventing and treating venous thromboembolism.

Low-molecular-weight heparins made anticoagulation less tied to hospital infusions and more compatible with ordinary life. For artists and writers recovering from illness or surgery, such practicality can mean returning sooner to work and movement, impacting the themes of resilience and recovery in contemporary poetry.